StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.57−0.13 (-3.51%)

Close on Nov 18, 2026Market cap $99.44MP/E –Yield –

Unicycive Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Unicycive Therapeutics's price to book ratio was 2.0× on Nov 11, 2026, against 3.6× a year earlier. Over the last 3 years it ranged from 0.8× to 10.0×, with a median of 3.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×−1.2
2025Dec 31, 20253.2×−6.4
2024Jan 31, 20249.6×+0.8
2023Dec 29, 20238.8×+7.0
2022Dec 30, 20221.8×+0.1
2021Dec 31, 20211.6×–

More Unicycive Therapeutics figures

See a number that looks wrong?